In Memoriam
In memoriam†
David Abia,
Ugo Bastolla,
Pablo Chacón,
Carme Fábrega,
Federico Gago,
Antonio Morreale,
Anna Tramontano,
David Abia
Bioinformatics Unit, Centro de Biología Molecular Severo Ochoa (CBMSO), Madrid, Spain
Search for more papers by this authorUgo Bastolla
Bioinformatics Unit, Centro de Biología Molecular Severo Ochoa (CBMSO), Madrid, Spain
Search for more papers by this authorPablo Chacón
Centro de Investigaciones Biológicas (CIB), CSIC, Madrid, Spain
Search for more papers by this authorCarme Fábrega
Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
Carme Fábrega's present address is Instituto de Investigación Biomédica (IRB) de Barcelona, Spain.
Search for more papers by this authorFederico Gago
Departmento de Farmacología, Universidad de Alcalá, Madrid, Spain
Search for more papers by this authorAntonio Morreale
Bioinformatics Unit, Centro de Biología Molecular Severo Ochoa (CBMSO), Madrid, Spain
Search for more papers by this authorAnna Tramontano
Department of Biochemical Sciences “Rossi Fanelli”, Universitádi Roma “La Sapienza”, Rome, Italy
Search for more papers by this authorDavid Abia,
Ugo Bastolla,
Pablo Chacón,
Carme Fábrega,
Federico Gago,
Antonio Morreale,
Anna Tramontano,
David Abia
Bioinformatics Unit, Centro de Biología Molecular Severo Ochoa (CBMSO), Madrid, Spain
Search for more papers by this authorUgo Bastolla
Bioinformatics Unit, Centro de Biología Molecular Severo Ochoa (CBMSO), Madrid, Spain
Search for more papers by this authorPablo Chacón
Centro de Investigaciones Biológicas (CIB), CSIC, Madrid, Spain
Search for more papers by this authorCarme Fábrega
Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
Carme Fábrega's present address is Instituto de Investigación Biomédica (IRB) de Barcelona, Spain.
Search for more papers by this authorFederico Gago
Departmento de Farmacología, Universidad de Alcalá, Madrid, Spain
Search for more papers by this authorAntonio Morreale
Bioinformatics Unit, Centro de Biología Molecular Severo Ochoa (CBMSO), Madrid, Spain
Search for more papers by this authorAnna Tramontano
Department of Biochemical Sciences “Rossi Fanelli”, Universitádi Roma “La Sapienza”, Rome, Italy
Search for more papers by this authorFirst published: 27 November 2009
†
The authors state no conflict of interest.
REFERENCES
- 1 Ortiz AR,Pisabarro MT,Gago F. Molecular model of the interaction of bee venom phospholipase A2 with manoalide. J Med Chem 1993; 36: 1866–1879.
- 2 Ortiz AR,Pisabarro MT,Gallego J,Gago F. Implications of a consensus recognition site for phosphatidylcholine separate from the active site in cobra venom phospholipases A2. Biochemistry 1992; 31: 2887–2896.
- 3 Pisabarro MT,Ortiz AR,Palomer A,Cabre F,Garcia L,Wade RC,Gago F,Mauleon D,Carganico G. Rational modification of human synovial fluid phospholipase A2 inhibitors. J Med Chem 1994; 37: 337–341.
- 4 Ortiz AR,Pisabarro MT,Gago F,Wade RC. Prediction of drug binding affinities by comparative binding energy analysis. J Med Chem 1995; 38: 2681–2691.
- 5 Magrans JO,Ortiz AR,Molins A,Lebouille PHP,Sánchez-Quesada J,Pons M,Gago F,de Mendoza J. A designed non-peptidic receptor that mimincs the phosphocoline binding site of the McPC603 antibody. Angew Chem Int Ed Eng 1996; 35: 2712–2715.
- 6 Cuevas C,Pastor M,Perez C,Gago F. Comparative binding energy (COMBINE) analysis of human neutrophil elastase inhibition by pyridone-containing trifluoromethylketones. Comb Chem High Throughput Screen 2001; 4: 627–642.
- 7 Lozano JJ,Pastor M,Cruciani G,Gaedt K,Centeno NB,Gago F,Sanz F. 3D-QSAR methods on the basis of ligand-receptor complexes. Application of COMBINE and GRID/GOLPE methodologies to a series of CYP1A2 ligands. J Comput Aided Mol Des 2000; 14: 341–353.
- 8 Martin-Santamaria S,Munoz-Muriedas J,Luque FJ,Gago F. Modulation of binding strength in several classes of active site inhibitors of acetylcholinesterase studied by comparative binding energy analysis. J Med Chem 2004; 47: 4471–4482.
- 9 Perez C,Pastor M,Ortiz AR,Gago F. Comparative binding energy analysis of HIV-1 protease inhibitors: incorporation of solvent effects and validation as a powerful tool in receptor-based drug design. J Med Chem 1998; 41: 836–852.
- 10 Rodriguez-Barrios F,Gago F. Chemometrical identification of mutations in HIV-1 reverse transcriptase conferring resistance or enhanced sensitivity to arylsulfonylbenzonitriles. J Am Chem Soc 2004; 126: 2718–2719.
- 11 Schleinkofer K,Wiedemann U,Otte L,Wang T,Krause G,Oschkinat H,Wade RC. Comparative structural and energetic analysis of WW domain-peptide interactions. J Mol Biol 2004; 344: 865–881.
- 12 Wang T,Wade RC. Comparative binding energy (COMBINE) analysis of OppA-peptide complexes to relate structure to binding thermodynamics. J Med Chem 2002; 45: 4828–4837.
- 13 Tomic S,Bertosa B,Wang T,Wade RC. COMBINE analysis of the specificity of binding of Ras proteins to their effectors. Proteins 2007; 67: 435–447.
- 14 Tomic S,Nilsson L,Wade RC. Nuclear receptor-DNA binding specificity: a COMBINE and Free-Wilson QSAR analysis. J Med Chem 2000; 43: 1780–1792.
- 15 Mou TC,Gille A,Suryanarayana S,Richter M,Seifert R,Sprang SR. Broad specificity of mammalian adenylyl cyclase for interaction with 2′,3′-substituted purine- and pyrimidine nucleotide inhibitors. Mol Pharmacol 2006; 70: 878–886.
- 16 Murcia M,Ortiz AR. Virtual screening with flexible docking and COMBINE-based models. Application to a series of factor Xa inhibitors. J Med Chem 2004; 47: 805–820.
- 17 Pastor M,Perez C,Gago F. Simulation of alternative binding modes in a structure-based QSAR study of HIV-1 protease inhibitors. J Mol Graph Model 1997; 15: 364–371,389.
- 18 Murcia M,Morreale A,Ortiz AR. Comparative binding energy analysis considering multiple receptors: a step toward 3D-QSAR models for multiple targets. J Med Chem 2006; 49: 6241–6253.
- 19 Wang T,Wade RC. Comparative binding energy (COMBINE) analysis of influenza neuraminidase-inhibitor complexes. J Med Chem 2001; 44: 961–971.
- 20 Damborsky J,Kmunicek J,Jedlicka T,Luengo S,Gago F,Ortiz AR,Wade RC. Rational redesign of haloalkane dehalogenases guided by comparative binding energy analysis. In: A Svendsen, M Dekker, editors. Enzyme functionality: design, engineering and screening. New York; 2004. pp 79–96.
- 21 Kmunicek J,Luengo S,Gago F,Ortiz AR,Wade RC,Damborsky J. Comparative binding energy analysis of the substrate specificity of haloalkane dehalogenase from Xanthobacter autotrophicus GJ10. Biochemistry 2001; 40: 8905–8917.
- 22 Lushington GH,Wallace NM,Guo JX. Reliable Prescreening of candidate nerve agent prophylaxes via 3D QSAR. DTIC Monit Ser 2005: 1–28.
- 23 Wang JL,Guo JX,Zhang QY,Wu JJ,Seifert R,Lushington GH. A conformational transition in the adenylyl cyclase catalytic site yields different binding modes for ribosyl-modified and unmodified nucleotide inhibitors. Bioorg Med Chem 2007; 15: 2993–3002.
- 24 Wang JL,Datta A,Lushington GH. Structure-based quantitative structure activity relationship analysis of Omuralide analogs in the 20S proteasome: a covalent inhibitor COMBINE study. Lett Drug Design Discov 2007; 4: 417–421.
- 25 Lushington GH,Guo JX,Wang JL. Whither combine? New opportunities for receptor-based QSAR. Curr Med Chem 2007; 14: 1863–1877.
- 26 Wade RC,Henrich S,Wang T. Using 3D protein structures to derive 3D-QSARs. Drug Discov Today Technol 2004; 1: 241–246.
- 27 Wade RC,Ortiz AR,Gago F. Comparative binding energy analysis. In: H Kubinyi, G Folkers, Y Martin, editors. 3D-QSAR in drug design, Vol 2: ligand-protein interactions and molecular similarity. Dordrecht, Netherland: Kluwer-ESCOM; 1998. pp 79–96.
- 28 Pisabarro MT,Ortiz AR,Serrano L,Wade RC. Homology modeling of the Abl-SH3 domain. Proteins 1994; 20: 203–215.
- 29 Pisabarro MT,Ortiz AR,Viguera AR,Gago F,Serrano L. Molecular modeling of the interaction of polyproline-based peptides with the Abl-SH3 domain: rational modification of the interaction. Protein Eng 1994; 7: 1455–1462.
- 30 Ortiz AR,Kolinski A,Rotkiewicz P,Ilkowski B,Skolnick J. Ab initio folding of proteins using restraints derived from evolutionary information. Proteins 1999;( Suppl 3): 177–185.
- 31 Ortiz AR,Kolinski A,Skolnick J. Fold assembly of small proteins using Monte Carlo simulations driven by restraints derived from multiple sequence alignments. J Mol Biol 1998; 277: 419–448.
- 32
Ortiz AR,Kolinski A,Skolnick J.
Tertiary structure prediction of the KIX domain of CBP using Monte Carlo simulations driven by restraints derived from multiple sequence alignments.
Proteins
1998;
30:
287–294.
10.1002/(SICI)1097-0134(19980215)30:3<287::AID-PROT8>3.0.CO;2-H CAS PubMed Web of Science® Google Scholar
- 33 Ortiz AR,Kolinski A,Skolnick J. Nativelike topology assembly of small proteins using predicted restraints in Monte Carlo folding simulations. Proc Natl Acad Sci USA 1998; 95: 1020–1025.
- 34 Skolnick J,Kolinski A,Ortiz AR. MONSSTER: a method for folding globular proteins with a small number of distance restraints. J Mol Biol 1997; 265: 217–241.
- 35 Skolnick J,Kolinski A,Ortiz AR. Reduced protein models and their application to the protein folding problem. J Biomol Struct Dyn 1998; 16: 381–396.
- 36 Fischer D,Elofsson A,Rychlewski L,Pazos F,Valencia A,Rost B,Ortiz AR,Dunbrack RL,Jr. CAFASP2: the second critical assessment of fully automated structure prediction methods. Proteins 2001;( Suppl 5): 171–183.
- 37 Fischer D,Rychlewski L,Dunbrack RL,Jr,Ortiz AR,Elofsson A. CAFASP3: the third critical assessment of fully automated structure prediction methods. Proteins 2003; 53 ( Suppl 6): 503–516.
- 38 Qian B,Ortiz AR,Baker D. Improvement of comparative model accuracy by free-energy optimization along principal components of natural structural variation. Proc Natl Acad Sci USA 2004; 101: 15346–15351.
- 39 Han R,Leo-Macias A,Zerbino D,Bastolla U,Contreras-Moreira B,Ortiz AR. An efficient conformational sampling method for homology modeling. Proteins 2008; 71: 175–188.
- 40 De Las Rivas J,Lozano JJ,Ortiz AR. Comparative analysis of chloroplast genomes: functional annotation, genome-based phylogeny, and deduced evolutionary patterns. Genome Res 2002; 12: 567–583.
- 41 Ortiz AR,Strauss CE,Olmea O. MAMMOTH (matching molecular models obtained from theory): an automated method for model comparison. Protein Sci 2002; 11: 2606–2621.
- 42 Lupyan D,Leo-Macias A,Ortiz AR. A new progressive-iterative algorithm for multiple structure alignment. Bioinformatics 2005; 21: 3255–3263.
- 43 Leo-Macias A,Lopez-Romero P,Lupyan D,Zerbino D,Ortiz AR. An analysis of core deformations in protein superfamilies. Biophys J 2005; 88: 1291–1299.
- 44 Leo-Macias A,Lopez-Romero P,Lupyan D,Zerbino D,Ortiz AR. Core deformations in protein families: a physical perspective. Biophys Chem 2005; 115: 125–128.
- 45 Pascual-Garcia A,Abia D,Ortiz AR,Bastolla U. Cross-over between discrete and continuous protein structure space: insights into automatic classification and networks of protein structures. PLoS Comput Biol 2009; 5: e1000331.
- 46 Gil-Redondo R. Implementation of an informatic platform for virtual screening of chemical libraries. Master Thesis, UNED, Madrid 2006.
- 47 Perez C,Ortiz AR. Evaluation of docking functions for protein-ligand docking. J Med Chem 2001; 44: 3768–3785.
- 48 Wang K,Murcia M,Constans P,Perez C,Ortiz AR. Gaussian mapping of chemical fragments in ligand binding sites. J Comput Aided Mol Des 2004; 18: 101–118.
- 49 Morreale A,Gil-Redondo R,Ortiz AR. A new implicit solvent model for protein-ligand docking. Proteins 2007; 67: 606–616.
- 50 Gil-Redondo R,Estrada J,Morreale A,Herranz F,Sancho J,Ortiz AR. VSDMIP: virtual screening data management on an integrated platform. J Comput Aided Mol Des 2009; 23: 171–184.
- 51 Ruiz FM,Gil-Redondo R,Morreale A,Ortiz AR,Fabrega C,Bravo J. Structure-based discovery of novel non-nucleosidic DNA alkyltransferase inhibitors: virtual screening and in vitro and in vivo activities. J Chem Inf Model 2008; 48: 844–854.
- 52 Blanco FJ,Yee A,Campos-Olivas R,Ortiz AR,Devos D,Valencia A,Arrowsmith CH,Rico M. Solution structure of the hypothetical protein Mth677 from Methanobacterium thermoautotrophicum: a novel alpha+beta fold. Protein Sci 2004; 13: 1458–1465.
- 53 Fabrega C,Farrow MA,Mukhopadhyay B,de Crecy-Lagard V,Ortiz AR,Schimmel P. An aminoacyl tRNA synthetase whose sequence fits into neither of the two known classes. Nature 2001; 411: 110–114.
- 54 Swairjo MA,Morales AJ,Wang CC,Ortiz AR,Schimmel P. Crystal structure of trbp111: a structure-specific tRNA-binding protein. EMBO J 2000; 19: 6287–6298.
- 55 Hurtado M,Lozano JJ,Castellanos E,Lopez-Fernandez LA,Harshman K,Martinez AC,Ortiz AR,Thomson TM,Paciucci R. Activationof the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells. Gut 2007; 56: 1266–1274.
- 56 Lozano JJ,Soler M,Bermudo R,Abia D,Fernandez PL,Thomson TM,Ortiz AR. Dual activation of pathways regulated by steroid receptors and peptide growth factors in primary prostate cancer revealed by Factor Analysis of microarray data. BMC Genomics 2005; 6: 109.
- 57 Martin V,Perales C,Abia D,Ortiz AR,Domingo E,Briones C. Microarray-based identification of antigenic variants of foot-and-mouth diseasevirus: a bioinformatics quality assessment. BMC Genomics 2006; 7: 117.
- 58 Sanchez-Carbayo M,Socci ND,Lozano JJ,Li W,Charytonowicz E,Belbin TJ,Prystowsky MB,Ortiz AR,Childs G,Cordon-Cardo C. Gene discovery in bladder cancer progression using cDNA microarrays. Am J Pathol 2003; 163: 505–516.
- 59 Bermudo R,Abia D,Ferrer B,Nayach I,Benguria A,Zaballos A,del Rey J,Miro R,Campo E,Martinez AC,Ortiz AR,Fernandez PL,Thomson TM. Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancer. BMC Cancer 2008; 8: 315.
- 60 Schamel WW,Risueno RM,Minguet S,Ortiz AR,Alarcon B. A conformation- and avidity-based proofreading mechanism for the TCR-CD3 complex. Trends Immunol 2006; 27: 176–182.
